The present invention relates to compounds of the general Formula (I) wherein(A) is a 5 or 6-membered aromatic or heteroaromatic ring； Ris cycloalkylor is aryl or heteroaryl, wherein at least one ring is aromatic in nature, unsubstitutedor substituted by 1 to 3 substituents selected from the group consisting of halogen,lower alkyl, lower alkyl substituted by halogen, lower alkoxy, lower alkoxysubstituted by halogen, -C(O) -lower alkyl, -S(O)-lower alkyl,nitro or cyano； R is hydrogen or lower alkyl； R is hydrogenor lower alkyl； R is halogen, lower alkyl, lower alkyl substitutedby halogen, lower alkoxy, lower alkoxy substituted by halogen or nitro； Ris hydrogen, halogen, lower alkyl or lower alkyl substituted by halogen； X isa bond, -(CH)-, -CHO- or -CHNH-；The dotted line denotes a bond or not； n is 1 or 2； m is 1, 2 or 3； and pharmaceuticallyacceptable acid addition salts thereof and their use in the treatment of neurologicaland neuropsychiatric disorders.
